Aminoglycosides Market Growth Is Reshaping Competitive Advantage Across The Industry
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Aminoglycosides Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The aminoglycosides market experienced robust expansion over the past few years, with its valuation projected to climb from $1.91 billion in 2025 to $2.02 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.8%. Strong demand in ophthalmic formulations, the widespread application of broad-spectrum antibiotics, traditional production methods, limited regulatory supervision in veterinary settings, and a high frequency of abdominal and urinary tract infections all contributed significantly to the market’s historical growth.
The aminoglycosides market is projected to experience a robust expansion over the coming years, reaching an estimated value of $2.56 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.0%. This anticipated growth in the forecast period is largely fueled by heightened research and development efforts focused on targeted aminoglycoside therapies, a growing public awareness regarding antibiotic resistance, the increasing implementation of advanced systems for drug delivery, an expanding market in veterinary healthcare, and the rising prominence of personalized medicine applications. Key trends expected to shape this period include a growing frequency of gram-negative infections, a greater incorporation of aminoglycosides within veterinary practices, the creation of innovative new aminoglycoside derivatives, a notable pivot towards injectable and targeted drug formulations, and broadening use cases in ophthalmic and inhalation-related treatments.
Download A Free Sample Report For Comprehensive Market Insights:
Aminoglycosides Market Industry Drivers: What Is Driving Revenue Growth?
A major factor projected to drive the aminoglycosides market forward is the increasing frequency of animal disease outbreaks. An animal disease is defined as any impairment of an animal’s normal state that interrupts or alters its essential functions. In veterinary practice, aminoglycosides such as amikacin and gentamicin are widely utilized. For example, in July 2025, GOV.UK, a UK government agency, reported that laboratory-confirmed leptospirosis cases in England rose from 70 in 2023 to 102 in 2024, marking a 45.7% increase. Furthermore, pasteurellosis cases totaled 890 in 2024, compared to 815 in 2023. As a result, the growing occurrence of animal disease outbreaks will continue to fuel the aminoglycosides market.
The growth of the aminoglycosides market is expected to be propelled by a rise in pet ownership. Pet ownership involves keeping and caring for animals, known as pets, within a living space. This trend enlarges the customer base, encourages a preventive healthcare mindset for animals, and drives investment in veterinary pharmaceuticals to meet the varied health requirements of companion animals. As an illustration, in March 2023, Improve International, a US-based veterinary educational resource, noted that 38 million pets live in 16.2 million UK households, accounting for approximately 57% of all households. Consequently, the increase in pet ownership is fueling the aminoglycosides market.
Aminoglycosides Market Segmentation: How Is The Market Structured Across Key Categories?
The aminoglycosides market covered in this report is segmented –
1) By Product: Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin, Other Products
2) By Route Of Administration: Injectables (Parenteral), Feed, Intra-Mammary, Topical, Oral
3) By Application: Veterinary, Skin Infection, Respiratory Diseases, UTI And Pelvic Diseases, Other Diseases
Aminoglycosides Market Growth Trends: What Is Influencing The Future Outlook?
Key players in the aminoglycosides market are concentrating on creating cutting-edge solutions, including improvements in manufacturing and formulation processes, to address the growing need for highly effective, next-generation antibiotics that can combat drug-resistant bacterial infections. These advancements in production techniques result in greater purity, stability, and therapeutic effectiveness when compared to conventional aminoglycoside methods. A notable example occurred in February 2024, when Cipla Limited, a pharmaceutical firm based in India, secured approval from the Central Drugs Standard Control Organization (CDSCO) for ZEMDRI (plazomicin), an intravenous aminoglycoside antibiotic, within the country. This medication is specifically designed for managing complicated urinary tract infections (cUTIs), such as pyelonephritis.
Aminoglycosides Market Competitive Landscape And Leading Companies
Major companies operating in the aminoglycosides market are Kremoint Pharma Pvt. Ltd., Vega Pharma Ltd., Jiangxi Bolai Pharmacy Co. Ltd., Xian Wison Biological Technology Co. Ltd., Hangzhou Uniwise International Co. Ltd., HuvePharma Inc., Yi Chang Veterinary Medicine Factory, Medson Pharmaceuticals, Medico Remedies Pvt. Ltd., Cipla Limited, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Zoetis Inc., Novartis AG, Johnson & Johnson Inc., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Zydus Lifescience Limited, Lupin Limited, Aurobindo Pharma Limited, Fresenius Kabi AG, Aspen Pharmacare Holdings Limited, Mylan N.V., Sanofi SA, Wyeth Pharmaceuticals Inc., Zhejiang Hisun Pharmaceutical Co. Ltd., GlaxoSmithKline plc, Allergan PLC, Bristol Myers Squibb Company
Access The Complete Aminoglycosides Market Report:
Aminoglycosides Market Global Footprint: Which Region Holds Market Leadership?
Asia-Pacific was the largest region in the aminoglycosides market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the aminoglycosides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
